Stanford Graduate School of Business (USA)
-
The Opioid Epidemic (B): Responses to the Crisis
Shotts, Ken; Melvin, SheilaCase SGSB-ETH18B-EDecision AnalysisBetween 1999 and 2017, almost 400,000 Americans died from an opioid overdose. An average of 130 died each day in 2017, six times the daily rate in 1999. These deaths were caused by both prescription opioids and illegal opioids like heroin and illicitly manufactured fentanyl, or IMF. The most common drugs involved in prescription opioid overdose deaths were methadone, oxycodone (like OxyContin), and hydrocodone (like Vicodin). The A case, which ...Starting at €5.74
-
Meta and Political Speech
Shotts, Ken; Melvin, SheilaCase SGSB-ETH34-EDecision AnalysisBy 2022, Meta was the world’s largest social media company, with around 3 billion users sharing 140 billion messages and a billion stories a day. Over 200 million businesses used Meta apps like Facebook, Instagram, and WhatsApp. Meta’s primary source of revenue was advertising. Its proclaimed mission was to “give people the power to build community and bring the world closer together” and its principles were to “give people a voice, build connect...Starting at €8.20
-
Tariffed!
Shotts, Ken; Melvin, SheilaCase SGSB-P94-EEconomicsThis case describes President Donald Trump’s steel and aluminum tariffs of 2018. The case covers the recent history of U.S. trade protectionism in these industries, as well as the domestic and international politics surrounding the Trump tariffs. The case discusses industry reaction to the tariffs, as well as their implementation by the Department of Commerce, and retaliation by other countries.Starting at €8.20
-
The Opioid Epidemic (A)
Shotts, Ken; Melvin, SheilaCase SGSB-ETH-18-EBusiness Ethics and Corporate Social ResponsibilityThis case provides an overview of the history and causes of the U.S. opioid epidemic. It begins with a history of opium and pain management, leading into a description of the current epidemic, its stages, and its scale. The case then presents possible causes of the epidemic: misleading marketing by drug companies, kickback schemes, irresponsible physicians and distributors, lobbying, and societal expectations about eliminating pain.Starting at €8.20